---
annotations:
- type: Pathway Ontology
  value: regulatory pathway
authors:
- MaintBot
- ReactomeTeam
- Anwesha
- Ryanmiller
description: Co-transcriptional pre-mRNA splicing is not obligatory. Pre-mRNA splicing
  begins co-transcriptionally and often continues post-transcriptionally. Human genes
  contain an average of nine introns per gene, which cannot serve as splicing substrates
  until both 5' and 3' ends of each intron are synthesized. Thus the time that it
  takes for pol II to synthesize each intron defines a minimal time and distance along
  the gene in which splicing factors can be recruited. The time that it takes for
  pol II to reach the end of the gene defines the maximal time in which splicing could
  occur co-transcriptionally. Thus, the kinetics of transcription can affect the kinetics
  of splicing.Any covalent change in a primary (nascent) mRNA transcript is mRNA Processing.  For
  successful gene expression, the primary mRNA transcript needs to be converted to
  a mature mRNA prior to its translation into polypeptide.  Eucaryotic mRNAs undergo
  a series of complex processing reactions; these begin on nascent transcripts as
  soon as a few ribonucleotides have been synthesized during transcription by RNA
  Polymerase II, through the export of the mature mRNA to the cytoplasm, and culminate
  with mRNA turnover in the cytoplasm.  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=72203
  Reactome].
last-edited: 2021-01-25
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP1889
- /instance/WP1889
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP1889.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: Co-transcriptional pre-mRNA splicing is not obligatory. Pre-mRNA splicing
    begins co-transcriptionally and often continues post-transcriptionally. Human
    genes contain an average of nine introns per gene, which cannot serve as splicing
    substrates until both 5' and 3' ends of each intron are synthesized. Thus the
    time that it takes for pol II to synthesize each intron defines a minimal time
    and distance along the gene in which splicing factors can be recruited. The time
    that it takes for pol II to reach the end of the gene defines the maximal time
    in which splicing could occur co-transcriptionally. Thus, the kinetics of transcription
    can affect the kinetics of splicing.Any covalent change in a primary (nascent)
    mRNA transcript is mRNA Processing.  For successful gene expression, the primary
    mRNA transcript needs to be converted to a mature mRNA prior to its translation
    into polypeptide.  Eucaryotic mRNAs undergo a series of complex processing reactions;
    these begin on nascent transcripts as soon as a few ribonucleotides have been
    synthesized during transcription by RNA Polymerase II, through the export of the
    mature mRNA to the cytoplasm, and culminate with mRNA turnover in the cytoplasm.  View
    original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=72203 Reactome].
  keywords:
  - 'SF3A3 '
  - 'GTF2F1 '
  - 'SF3B3 '
  - 'PRPF3 '
  - 'ELAVL1 '
  - 'NUP107 '
  - 5'-end cleaved mRNA
  - 'U4 snRNA '
  - 'SRSF1 '
  - Intermediate C
  - Mature Intronless
  - 'PDCD7 '
  - 'SRSF9 '
  - 'PPIH '
  - ZRSR2
  - ATP
  - 'TFIP11 '
  - U12 snRNP
  - PAPOLA
  - YBX1
  - 'NUP43 '
  - 'SF1 '
  - 'DHX15 '
  - 'CPSF2 '
  - 'POLR2A '
  - POLDIP3
  - ligated exon
  - NCBP2
  - Nucleoplasmic mature
  - 'PRPF31 '
  - 'CSTF3 '
  - intronless
  - 'POLR2G '
  - 'SEH1L-2 '
  - ATAC A Complex
  - intronless derived
  - 'CCAR1 '
  - 'SUGP1 '
  - 'PRPF19 '
  - 'RAE1 '
  - 'SF3B1 '
  - 'HNRNPF '
  - 'POLR2F '
  - '2xMe-SNRPD3 '
  - 'METTL3 '
  - Pol II
  - 'SEH1L-1 '
  - 'PAPOLA '
  - 'ZC3H11A '
  - CDC40
  - 'FYTTD1 '
  - 'DHX16 '
  - 'WDR33 '
  - 'U5 snRNA '
  - 'SF3B4 '
  - 'SARNP '
  - 'Mature intronless derived mRNA '
  - 'HNRNPK '
  - 'SNRNP27 '
  - 'SLBP '
  - 'LSM3 '
  - 'NUDT21 '
  - 'RNPC3 '
  - SRSF5
  - 'CDC40 '
  - 'EFTUD2 '
  - '3''-end cleaved mRNA with spliced exons '
  - 'Mature Intronless transcript derived Histone mRNA '
  - 'hTra2 '
  - 'NUP98-4 '
  - (Bact) Complex
  - 'PLRG1 '
  - 'PRPF4 '
  - pre-mRNA:CBC:RNA
  - 'CSTF1 '
  - PABPN1
  - Spliced
  - 'METTL14 '
  - 'LSM4 '
  - 'PRPF8 '
  - 'NUP133 '
  - ATAC C Complex
  - '2xMe-SNRPD1 '
  - 'CPSF3 '
  - mRNA 3'-end cleavage
  - GLE1
  - EIF4A3
  - mRNA:CBC:EJC:TREX:SRSF proteins
  - 'FIP1L1 '
  - 'ZRSR2 '
  - NXF1,2:NXT1::polyadenylated, capped mRNA:CBC:EJC:TREX:SRSF proteins
  - lariat containing
  - 'TXNL4A '
  - 'CPSF7 '
  - derived mRNA
  - 'CRNKL1 '
  - Histone
  - 'RBMX '
  - SYF2
  - 'THOC2 '
  - SF3B
  - CHTOP
  - 'GPKOW '
  - RNA
  - SRRM1:SRRM2
  - SRSF9
  - 'THOC7 '
  - 'HNRNPA0 '
  - AQR
  - 'ATP '
  - 'NUPL2 '
  - 'SNRPE '
  - CPSF
  - 'CWC25 '
  - 'NUP58-1 '
  - 'LSM8 '
  - HNRNPA2B1
  - 'GTF2F2 '
  - 'NHP2L1 '
  - (NPC)
  - CD2BP2
  - 'NUP205 '
  - 'DHX38 '
  - mRNA:CBC:EJC:POLDIP3
  - 'MAGOH '
  - 'SRSF6 '
  - UPF3B
  - Spliced mRNP
  - EIF4E
  - LSM2-8 complex
  - 'FUS '
  - 'CLP1 '
  - 'HNRNPA2B1 '
  - 'SNW1 '
  - 'SRSF2 '
  - DHX16
  - 'Mature intronless transcript derived mRNA '
  - 'SRSF11 '
  - 'HNRNPR '
  - 'PRPF38A '
  - DDX39B:ADP
  - 'RNPS1 '
  - 'POLR2D '
  - intron-containing
  - 'LSM5 '
  - mRNA:SLBP:eIF4E
  - TRA2B
  - mRNA:SLBP:TAP:Aly/Ref complex
  - LUZP4
  - SF1
  - GPKOW
  - Intronless
  - 'NUP62 '
  - CWC25
  - 'MAGOHB '
  - 'AAAS '
  - polyadenylated,
  - 'SMNDC1 '
  - 'NUP88 '
  - 'SNRNP200 '
  - 'U2AF2 '
  - 'NUP98-3 '
  - Complex
  - 'DHX9 '
  - HNRNPU
  - Spliceosomal B
  - 'ISY1 '
  - 'WBP4 '
  - 'NUP188 '
  - pre-mRNA:CBC
  - SRSF7
  - 'CSTF2 '
  - Cap Binding Complex
  - 'Mature intronless transcript derived Histone mRNA '
  - 'U6 snRNA '
  - HNRNPF
  - transcript
  - ATAC C Complex with
  - 'hSLU7 '
  - SRSF2
  - 'excised intron '
  - 'PRCC '
  - (phosphorylated):TFIIF complex
  - 'SF3A2 '
  - 'SNRPB2 '
  - 'U6 ATAC snRNA '
  - 'HNRNPH1 '
  - 'ADP '
  - 'NDC1 '
  - 'NXT1 '
  - 'DNAJC8 '
  - SRSF6
  - 'HSPA8 '
  - C (B*) Complex
  - 'SNRPA1 '
  - 'LUZP4 '
  - 'UPF3B '
  - 'SNRNP40 '
  - SRSF3
  - 'p-S5-POLR2A '
  - Spliceosomal E
  - 'POLR2L '
  - HNRNPL
  - 'Me2-R108,R112-SNRPN '
  - HNRNPD
  - 'SRSF7 '
  - 'ZMAT5 '
  - 'POLR2I '
  - 'U2AF1 '
  - 'POLR2B '
  - 'PCBP2 '
  - 'capped, methylated pre-mRNA '
  - U4 snRNP
  - 'HNRNPL '
  - II
  - 3' end cleaved,
  - SRSF4
  - mRNA:eIF4E Complex
  - 'CPSF4 '
  - SF3A
  - 'CWC27 '
  - 'PPWD1 '
  - 'U2AF1L4 '
  - 'NUP153 '
  - 'SNRPA '
  - XAB2
  - SRSF10
  - 'NUP37 '
  - NPC:NXF1,2:NXT1:EJC:CBC:mRNA
  - (N6-adenosine)-methyltransferase
  - 'PCBP1 '
  - HNRNPK
  - factor
  - 'Me2-R108,R112-SNRPB '
  - 'HNRNPU '
  - HNRNPUL1
  - Mature SLBP
  - mRNA
  - FUS
  - 'CDC5L '
  - 'DDX23 '
  - 'CHERP '
  - DNAJC8
  - HNRNPC
  - 'PRPF40A '
  - CstF
  - PCBP1
  - U2AF2
  - 'NCBP1 '
  - independent Histone
  - 'SNRPD2 '
  - 'RANBP2 '
  - pre-EJC:Spliceosomal
  - Nuclear Pore Complex
  - SRRT
  - (phosphorylated)
  - 'CPSF1 '
  - 'NUP98-5 '
  - 'YBX1 '
  - 'POLDIP3 '
  - U5 snRNP
  - SNW1
  - 'NUP160 '
  - 'BUD31 '
  - DDX39A,B
  - DDX5
  - 'U1 snRNA '
  - 'GCFC2 '
  - PTBP1
  - SRSF11
  - PRPF40A
  - 'PPIL4 '
  - HNRNPA0
  - hSLU7
  - Polyadenylation
  - Pi
  - 'RBM17 '
  - mRNA:CBC:EJC:TREX
  - 'HNRNPC '
  - 'POLR2C '
  - Spliceosomal A
  - 'SF3A1 '
  - 'SRRM2 '
  - ELAVL1
  - mRNA:SLBP:CBP80:CBP20
  - NXF1
  - HNRNPM
  - SART1
  - 'CD2BP2 '
  - Mature
  - capped
  - 'CTNNBL1 '
  - RNPS1
  - HNRNPH2
  - 'THOC1 '
  - 'XAB2 '
  - 'NCBP2 '
  - lariat containing,
  - derived
  - 'SNRNP48 '
  - 'TPR '
  - 'SNRPC '
  - U4 ATAC snRNP
  - 'DDX39B '
  - DHX9
  - 'THOC5 '
  - 'SF3B2 '
  - RBM5
  - mRNA:eIF4E complex
  - 'CSTF2T '
  - 'NXF1 '
  - CCAR1
  - 'PPIE '
  - C:pre-mRNP:CBC
  - mRNA:TAP:Aly/Ref
  - 'NUP93 '
  - 'HNRNPA1 '
  - 'RBM8A '
  - 'SNRNP25 '
  - 'DDX46 '
  - 'POM121 '
  - CWC27
  - Spliceosomal
  - 'ALYREF '
  - 'SNRPF '
  - post exon ligation
  - U4 ATAC:U5:U6 ATAC
  - USP39
  - 'NUP85 '
  - HNRNPH1
  - CASC3
  - 'PQBP1 '
  - CF I
  - 'DDX5 '
  - 'LSM6 '
  - '3''-polyadenylated, capped pre-mRNA '
  - 'USP39 '
  - U11 snRNP
  - 'SRRM1 '
  - Spliceosomal Active
  - 5'-end cleaved
  - 'POLR2J '
  - 'NUP210 '
  - 'THOC3 '
  - U2 snRNP
  - 'NUP155 '
  - SNRNP27
  - 'ZCRB1 '
  - 'CWC15 '
  - ELAVL2
  - SRSF1
  - NCBP1
  - Transcript Derived
  - 'PRPF6 '
  - 'CHTOP '
  - CWC22
  - NPC:NXF1:NXT1:EJC:CBC:mRNA
  - Magoh-Y14 complex
  - U1 snRNP
  - 'SNRPG '
  - 'POLR2H '
  - WBP4
  - 'NUP35 '
  - 'mRNA '
  - 'NUP54 '
  - 'RBM22 '
  - 'SYMPK '
  - 'NUP50 '
  - 'DDX42 '
  - PPIL
  - Spliceosomal active
  - 'POLR2E '
  - PRPF38A
  - HNRNPR
  - RBMX
  - HNRNPA3
  - PPWD1
  - 'SRRT '
  - ZC3H11A
  - 'SRSF4 '
  - 'SRSF3 '
  - U6 ATAC snRNP
  - 'HNRNPH2 '
  - 'HNRNPA3 '
  - 'PTBP1 '
  - 'capped pre-mRNA '
  - 'U12 snRNA '
  - PPIE
  - 'PPIL6 '
  - 'HNRNPD '
  - BUD31
  - 'EIF4A3 '
  - 'CWC22 '
  - HNRNPA1
  - 'AQR '
  - 'NUP214 '
  - 'PABPN1 '
  - U2AF1,U2AF1L4
  - SARNP
  - 'SART1 '
  - C complex with
  - 'CF I - 68 kDa subunit '
  - 'HNRNPM '
  - 'U4atac snRNA '
  - (CBC)
  - 'CF I - 72 kDa subunit '
  - 'SF3B5 '
  - 'PCF11 '
  - 'POM121C '
  - 'POLR2K '
  - PRP19-CDC5L complex
  - containing complex
  - 'DDX39A '
  - 'WTAP '
  - 'U2 snRNA '
  - 'ELAVL2 '
  - 'PPIL1 '
  - complex
  - THO complex
  - 'NUP58-2 '
  - CF II
  - 'LSM2 '
  - transcript derived
  - 'LSM7 '
  - 'PPIL3 '
  - 'RBM5 '
  - capped, methylated
  - 'BCAS2 '
  - DHX38
  - ISY1
  - 'SF3B6 '
  - CRNKL1
  - pre-mRNP:CBC
  - 'TRA2B '
  - ATAC B Complex
  - 'WBP11 '
  - 'SNRNP70 '
  - Cleavage and
  - RBM22
  - ALYREF, FYTTD1,
  - 'CASC3 '
  - polymerase
  - 'SKIV2L2 '
  - 'NXF2 '
  - U4:U5:U6 tri-snRNP
  - 'U2SURP '
  - ALYREF
  - 'SRSF5 '
  - 'EIF4E '
  - NXF1,2:NXT1
  - 'PHF5A '
  - 'HNRNPUL1 '
  - 'PUF60 '
  - 'SYF2 '
  - 'mRNA with spliced exons '
  - 'THOC6 '
  - 'SNRNP35 '
  - PRCC
  - 'U11 snRNA '
  - Mature intronless
  - SUGP1
  - 'SEC13 '
  - PCBP2
  - 'lariat containing 5''-end cleaved mRNA '
  license: CC0
  name: Processing of Capped Intron-Containing Pre-mRNA
seo: CreativeWork
title: Processing of Capped Intron-Containing Pre-mRNA
wpid: WP1889
---